Table 1 Associations between the selected SNPs and gastric cancer risk

From: A genetic variant of miR-148a binding site in the SCRN1 3′-UTR is associated with susceptibility and prognosis of gastric cancer

SNPs

Genetic model

Genotype

Cases

Controls

P a

Crude OR (95% CI)

Adjusted OR (95% CI)b

rs6976789

Codominant

CC

481

653

0.100

1.00 (reference)

1.00 (reference)

  

CT

255

278

 

1.25 (1.01–1.53)

1.25 (1.02–1.54)

  

TT

17

18

 

1.28 (0.66–2.51)

1.28 (0.65–2.51)

 

Dominant

CC

481

653

0.032

1.00 (reference)

1.00 (reference)

  

CT+TT

272

296

 

1.25 (1.02–1.53)

1.25 (1.02–1.53)

 

Recessive

CC+CT

736

931

0.602

1.00 (reference)

1.00 (reference)

  

TT

17

18

 

1.20 (0.61–2.33)

1.19 (0.61–2.32)

rs2235749

Codominant

AA

564

690

0.545

1.00 (reference)

1.00 (reference)

  

AG

170

236

 

0.88 (0.70–1.11)

0.89 (0.71–1.11)

  

GG

19

23

 

1.01 (0.55–1.87)

1.01 (0.54–1.87)

 

Dominant

AA

564

690

0.308

1.00 (reference)

1.00 (reference)

  

AG+GG

189

259

 

0.89 (0.72–1.11)

0.90 (0.72–1.12)

 

Recessive

AA+AG

734

926

0.900

1.00 (reference)

1.00 (reference)

  

GG

19

23

 

1.04 (0.56–1.93)

1.04 (0.56–1.92)

  1. aTwo-sided χ2 test for either genotype distributions between cases and controls.
  2. bAdjusted for age and sex in logistic regression model.